Gold Price Struggles Amidst Economic Uncertainty The Current Situation The price of gold (XAU/USD) is currently facing challenges as it struggles to capitalize on an overnight bounce from a nearly two-week low of $2,472-2,471. The precious metal is oscillating in a narrow trading band during the Asian session on Thursday. Despite the bounce, the downside…
FDA Approves Coherus’ CIMERLI™ Introducing Coherus’ Latest FDA Approved Product Coherus Biosciences, a leading biotechnology company, has received FDA approval for their newest product, CIMERLI™. This marks Coherus’ third FDA-approved product and is the first of four new product launches planned by the end of 2023. The launch of CIMERLI™ is highly anticipated in the…
Important Investor Alert: In a significant development for investors, Levi & Korsinsky, LLP, a prominent securities law firm, has announced the filing of a class action lawsuit against ModivCare Inc. (“ModivCare” or the “Company”) (NASDAQ: MODV) on February 24, 2025. The complaint, which was filed in the United States District Court for the Southern District…
Fortune Brands Recognized as One of The Wall Street Journal’s Best-Managed Companies of 2024 DEERFIELD, Ill.–(Business Wire)– Fortune Brands Innovations, Inc. (FBIN or “Fortune Brands”), a leading innovation company dedicated to enhancing everyday experiences by transforming spaces into sanctuaries, has been recognized on The Wall Street Journal’s prestigious list of the Top 250 Best-Managed Companies…
Impressive Gain for Tilray Brands Shares of Tilray Brands (TLRY 5.75%) Surge 7.5% Investors and analysts were pleasantly surprised as Tilray Brands’ stock soared by 7.5% on Wednesday, with shares gaining 5.75% overall. This sudden surge in stock value undoubtedly caught the attention of many in the financial world, sparking discussions and analysis on what…
Vyant Bio Commences a Cash Preservation Plan Introduction CHERRY HILL, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of…
Breaking News Alert! Frontier Group Holdings to Release Q4 2024 Financial Results Get ready, folks! Frontier Group Holdings, the cool parent company of Frontier Airlines, is set to drop some financial knowledge bombs on us on February 7, 2025. Mark your calendars! Alright, listen up fellow travelers and finance enthusiasts! It’s that time of year…
Investigation Commenced by Levi & Korsinsky into JinkoSolar Holding Co., Ltd. NEW YORK, NY – In a recent press release, Levi & Korsinsky, a leading securities law firm, announced that it has initiated an investigation into potential securities laws violations by JinkoSolar Holding Co., Ltd. (NYSE: JKS). Background on JinkoSolar Holding Co., Ltd. JinkoSolar Holding…
